期刊文献+

乙肝相关肝细胞癌的分子机制研究新进展 被引量:7

Molecular mechanism of hepatitis B virus- induced hepatocellular carcinoma
暂未订购
导出
摘要 肝细胞癌是最常见的恶性肿瘤之一,同时也是排列全球第三位的肿瘤相关致死原因。其发病率在我国仅次于肺癌,居第二位。乙肝病毒是一类DNA病毒,它主要感染肝细胞并引起一系列持续且较急性的肝脏病变。尽管有大量流行病学研究证明慢性乙型肝炎在肝癌的发生发展过程中发挥了重要的作用,但是其潜在的病毒导向致瘤的分子作用机制尚存在巨大的争议。本文系统总结相关文献,讨论乙肝病毒在原发性肝癌的致瘤过程中的相关分子机制。 Hepatocellular carcinoma (HCC) is the third leading cause of cancer- related deaths worldwide, and morbidity is second only to lung cancer in our country. As DNA virus, hepatitis B virus (HBV) infects hepatocellular and induces a series of acute hepatopathy. Although epidemiologic studies showed that HBV have a core status in the development of hepatocellular carcinoma,hugely controversy is still remained. By reviewing related literature, this pa- per mainly summarizes the molecule mechanism of HBV in the occurrence and development of HCC.
出处 《现代肿瘤医学》 CAS 2015年第8期1156-1159,共4页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(编号:81172020 81372262)
关键词 肝细胞癌 乙肝病毒 分子机制 致瘤性 hepatocellular carcinoma(HCC) hepatitis B virus (HBV) molecule mechanism oncogenicity
  • 相关文献

参考文献5

二级参考文献171

  • 1刘俊田,岳杰,任秀宝,李慧.乳腺癌患者外周血CD_4^+CD_(25)^+调节性T细胞的检测及意义[J].中华肿瘤杂志,2005,27(7):423-425. 被引量:30
  • 2张蘋,张利宁,朱法良,王群,王晓燕,李海艳,刘春梅,高飞,刘成虎.肝癌荷瘤小鼠调节性T细胞数量的改变及其与肿瘤生长的关系[J].中华肿瘤杂志,2007,29(5):342-345. 被引量:6
  • 3Khazaie K, yon Boehmer H. The impact of CD4^+ CD25^+ Treg on tumor specific CD8^+ T cell cytotoxicity and cancer. Semin Cancer Biol, 2006, 16:124-136.
  • 4Kono K, Kawaida H, Takahashi A, et al. CD4 ( + ) CD25^high regulatory T cells increase with tumor stage in patients with gastric and esophageal cancers. Cancer Immunol Immunother, 2006, 55 : 1064-1071.
  • 5Unitt E, Marshall A, Gelson W, et al. Tumour lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol, 2006, 45:246-253.
  • 6Roncarolo MG, Levings MK. The role of different subsets of T regulatory cells in controlling autoimmunity. Curr Opin Immunol, 2000, 12:676-683.
  • 7Zhou WP. Regulatory T cells, tumor immunity and immunotherapy. Nat Rev Immunol, 2006, 6:295-307.
  • 8Ormandy LA, Hillemann T, Wedemeyer H, et al. Increased populations of regulatory T cells in peripheral blood of patients with hepatocellular carcinoma. Cancer Res, 2005,65:2457-2464.
  • 9Unitt E, Rushbrook SM, Marshall A, et al. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology, 2005, 41:722-730.
  • 10Curiel TJ, Coukos G, Zou LH, et al. Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med, 2004, 10:942-949.

共引文献133

同被引文献94

引证文献7

二级引证文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部